identified EFNA3, a member of the ephrin type A ligands, is induced by hypoxia-inducible factor in human tumors and this induction is predictive of poor prognosis and increased risk of metastasis in breast cancer patients (12). This evidence concerns the gene EFNA3 and breast cancer.